0001493152-18-008646.txt : 20180613
0001493152-18-008646.hdr.sgml : 20180613
20180613215426
ACCESSION NUMBER: 0001493152-18-008646
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180611
FILED AS OF DATE: 20180613
DATE AS OF CHANGE: 20180613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mangiardi Vito J
CENTRAL INDEX KEY: 0001339044
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38185
FILM NUMBER: 18897986
MAIL ADDRESS:
STREET 1: 12 POINT GALLINAS ROAD
CITY: SAN RAFAEL
STATE: CA
ZIP: 94903
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PRESSURE BIOSCIENCES INC
CENTRAL INDEX KEY: 0000830656
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 042652826
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 14 NORFOLK AVENUE
CITY: SOUTH EASTON
STATE: MA
ZIP: 02375
BUSINESS PHONE: 5082301828
MAIL ADDRESS:
STREET 1: 14 NORFOLK AVENUE
CITY: SOUTH EASTON
STATE: MA
ZIP: 02375
FORMER COMPANY:
FORMER CONFORMED NAME: BOSTON BIOMEDICA INC
DATE OF NAME CHANGE: 19960812
4
1
form4.xml
X0306
4
2018-06-11
0
0000830656
PRESSURE BIOSCIENCES INC
PBIO
0001339044
Mangiardi Vito J
12 POINT GALINOS ROAD
SAN RAFAEL
CA
94903
1
0
0
0
SERIES AA CONVERTIBLE PREFERRED STOCK
2.50
2018-06-11
4
J
0
4.4
2500
A
2018-06-11
2019-06-11
COMMON STOCK
4400
4.4
D
COMMON STOCK WARRANT
3.50
2018-06-11
4
J
0
4400
A
2018-06-11
2023-06-11
COMMON STOCK
4400
4400
D
COMMON STOCK WARRANT
3.50
2018-06-11
4
J
0
596
A
2016-03-31
2021-03-31
COMMON STOCK
596
596
D
On June 11, 2018, Pressure BioSciences, Inc. (the "Issuer") entered into a letter agreement with Mr. Mangiardi (the "Reporting Person"). The Reporting Person previously held a convertible debenture with a face value of $11,000 (the "Debenture") and warrants to purchase common stock (the "Debenture Warrants"). Pursuant to the letter agreement, the Reporting Person agreed to convert the principal due to him pursuant to the Debenture into shares of Series AA Convertible Preferred Stock with a conversion price of $2.50 per share. The Reporting Person was also: (a) issued amended Debenture Warrants (originally issued on March 31, 2016) such that the exercise price is now $3.50 per share; and (b) issued a new warrant with an exercise price of $3.50 per share to purchase such number of shares of common stock as equal 100% of the number of shares of common stock issuable upon conversion of the Series AA Convertible Preferred Stock shares received as a result of the Debenture conversion.
/s/ Vito J. Mangiardi
2018-06-13